📰 6 sources covering this story

FDA clears Roche and Eli Lilly's Alzheimer's blood test for primary and specialty care

First covered 6 hrs ago · latest take 52 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

FDA clears Roche and Eli Lilly's Alzheimer's blood test for primary and specialty care
Quartz
Quartz52 mins ago
FDA clears Roche and Eli Lilly's Alzheimer's blood test for primary and specialty care
The Elecsys pTau217 test can help doctors assess amyloid pathology in people 55 and older showing signs of cognitive decline
Roche, Eli Lilly’s Alzheimer’s blood test gets US FDA clearance
The nod follows European approval for the Elecsys pTau217 test in May.
CTV News
CTV News4 hrs ago
Roche, Eli Lilly’s Alzheimer’s blood test gets U.S. FDA clearance
The U.S. Food and Drug Administration (FDA) has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer’s disease in people aged 55 and older with cognitive decline.
Forbes
Forbes4 hrs ago
FDA Clears Roche And Eli Lilly’s Alzheimer’s Blood Test
FDA Clears Roche And Eli Lilly’s Alzheimer’s Blood Test  Forbes
Reuters
Reuters5 hrs ago
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance  Reuters
Wall Street Journal
Wall Street Journal🏁 first to report6 hrs ago
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly - WSJ
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly  WSJ
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →